Brief: Jazz Pharmaceuticals Announces CEO Succession Plan
16/12/2024 21:51
Dec 16 (Reuters) - Jazz Pharmaceuticals PLC JAZZ.O :
* JAZZ PHARMACEUTICALS ANNOUNCES CEO SUCCESSION PLAN
* JAZZ PHARMACEUTICALS PLC - BRUCE COZADD TO RETIRE AS CEO
BY END
OF 2025
* JAZZ PHARMACEUTICALS PLC - ON TRACK TO MEET 2024 REVENUE
GUIDANCE OF $4.0-$4.1 BILLION
* JAZZ PHARMACEUTICALS PLC: BRUCE COZADD WILL CONTINUE AS
CHAIR
OF BOARD
Source text: ID:nPntp2SYa
Further company coverage: JAZZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jazz Pharmaceuticals
See all newsBrief: Jazz Pharmaceuticals Enters Amendment No. 4 To Credit Agreement On Sept 23, 2026
U.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
Jazz Pharma dips after upsized $1.1 bln convertible offering
Brief: Jazz Pharmaceuticals Announces Private Offering Of $1.0 Billion Of Exchangeable Senior Notes Due 2032